Viewing nowCombinationBildaMet Tablet 50/500 mg
Vildagliptin Nitrate 60.4mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyeongbo Pharmaceutical Co., Ltd.

MFDS item code 202107714 · Approved 2021.11.30 · Insurance code 665003130
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to assist in blood sugar control in patients with type 2 diabetes by combining vildagliptin and metformin. It can effectively manage blood sugar levels when administered alongside dietary and exercise therapy. This combination therapy contributes to the stable maintenance of blood sugar levels. Therefore, this medication helps improve blood sugar control in diabetes patients.
For the treatment of patients with type 2 diabetes, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding vildagliptin 100mg and metformin 2000mg. Doses of vildagliptin greater than 100mg per day are not recommended. This medicine should generally be taken with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients with no previous antidiabetic drug treatment whose blood glucose is inadequately controlled with monotherapy: The initial dose is 1 tablet of this medicine 50/500mg once daily; the dose may be gradually increased to 1 tablet of 50/1000mg twice daily. 2. Patients switching from concomitant vildagliptin and metformin therapy: Patients switching from concomitant vildagliptin and metformin therapy to this medicine may start at their previous doses of vildagliptin and metformin. If a dose of this medicine is missed, take it with the next meal unless it is time to take the missed dose; do not take a double dose at one time to make up for a missed dose.
This medication has the potential to cause severe lactic acidosis or hypoglycemia, and caution is required. It should not be used in patients with moderate to severe renal dysfunction or those with heart failure or liver dysfunction. Additionally, it should be temporarily discontinued in cases of acute infections, severe trauma, or unstable physical conditions such as pre- and post-surgery. It should also not be administered to pregnant or nursing women. It is important to maintain regular meals and appropriate exercise during the use of this medication, and interactions with other medications should be considered. In particular, alcohol consumption may increase the risk of lactic acidosis and should be avoided. This medication should be regularly monitored for liver and kidney function, and any unusual symptoms should be reported to healthcare professionals immediately. If symptoms of hypoglycemia occur, it is necessary to intake appropriate sugars immediately. Activities that require alertness, such as driving or operating machinery, should be avoided in the presence of dizziness or symptoms of hypoglycemia. Keep out of reach of children, and do not transfer to another container arbitrarily.
Lactic acidosis, hypoglycemia, hepatitis, liver dysfunction, elevated transaminase levels, angioedema, tremors, headache, dizziness, fatigue, nausea, gastroesophageal reflux, diarrhea, bloating, chills, decreased blood sugar, asthenia, hyperhidrosis, constipation, arthralgia, upper respiratory tract infection, nasopharyngitis, peripheral edema, nausea, vomiting, diarrhea, abdominal pain, decreased appetite, taste disorders, skin reactions (erythema, itching, hives), pancreatitis, hives, blisters, exfoliative skin lesions, severe and disabling arthralgia, cutaneous vasculitis, dyspepsia, abdominal discomfort, gastrointestinal abnormalities, elevated serum amylase, increased lipase, acute pancreatitis, vesicular pemphigoid, myalgia, paresthesia, fever, edema, swelling of hands and feet, increased creatine phosphokinase, elevated AST, increased C-reactive protein, elevated myoglobin levels
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and should be kept in a cool place below 30 degrees Celsius to maintain efficacy.
Bright yellow oval film-coated tablet
Bottle - 30 tablets/bottle, Bottle - 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationVildagliptin Nitrate 60.4mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyeongbo Pharmaceutical Co., Ltd.
CombinationVildagliptin Nitrate 60.4mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationVildagliptin Nitrate 60.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.